Literature DB >> 22922026

Data to guide the "test and treat era" of hepatitis C.

John W Ward, David B Rein, Bryce D Smith.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22922026     DOI： 10.1053/j.gastro.2012.08.027

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  5 in total

1.  Prevalence of Diagnosed and Undiagnosed Hepatitis C in a Midwestern Urban Emergency Department.

Authors:  Michael S Lyons; Vidhya A Kunnathur; Susan D Rouster; Kimberly W Hart; Matthew I Sperling; Carl J Fichtenbaum; Kenneth E Sherman
Journal:  Clin Infect Dis       Date:  2016-02-21       Impact factor: 9.079

2.  Chronic hepatitis C virus (HCV) burden in Rhode Island: modelling treatment scale-up and elimination.

Authors:  A I Soipe; H Razavi; D Razavi-Shearer; O Galárraga; L E Taylor; B D L Marshall
Journal:  Epidemiol Infect       Date:  2016-08-05       Impact factor: 2.451

3.  Comparison of Elecsys Anti-HCV II Assay With Other HCV Screening Assays.

Authors:  Dongdong Li; Siyuan Zhu; Tingting Wang; Jingna An; Lanlan Wang; Chuanmin Tao
Journal:  J Clin Lab Anal       Date:  2015-12-14       Impact factor: 2.352

4.  Mechanism of inhibition for BMS-791325, a novel non-nucleoside inhibitor of hepatitis C virus NS5B polymerase.

Authors:  Karen L Rigat; Hao Lu; Ying-Kai Wang; Argyrides Argyrou; Caroline Fanslau; Brett Beno; Yi Wang; Jovita Marcinkeviciene; Min Ding; Robert G Gentles; Min Gao; Lynn M Abell; Susan B Roberts
Journal:  J Biol Chem       Date:  2014-10-09       Impact factor: 5.157

5.  A descriptive model of patient readiness, motivators, and hepatitis C treatment uptake among Australian prisoners.

Authors:  Lorraine Yap; Susan Carruthers; Sandra Thompson; Wendy Cheng; Jocelyn Jones; Paul Simpson; Alun Richards; Hla-Hla Thein; Paul Haber; Andrew Lloyd; Tony Butler
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.